EUVIMEDEUVIMED entdecken
Crossref

Biodegradable Acid‐Responsive Nanocarrier for Enhanced Antibiotic Therapy Against Drug‐Resistant Helicobacter Pylori via Urease Inhibition

Huizhen Fan, Ka Ioi Wong, Yingying Ma, Ming Li, Hanqing Li, Li Wei, Shen Wang, Min Yao, Min Lu

Advanced Functional Materials · 2025-01 · 35 (2)

DOI: 10.1002/adfm.202412893 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 18.11.2024. Verfasst von Huizhen Fan und 8 weiteren Autor:innen. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai Municipality, National Key Research and Development Program of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metal ion‐based inhibition of urease activity is a promising strategy for treating Helicobacter pylori ( H. pylori ) infections. However, the challenges of safe delivery and reducing cytotoxicity persist. In this study, an innovative nanocarrier capable of acid‐responsive release of Ag + and antibiotics is developed, with complete degradation after treatment. Mesoporous organosilica nanoparticle (MON) is encapsulated with hyaluronic acid (HA) to prevent drug leakage and further coated with bacterial outer membrane vesicle (OMV) from Escherichia coli Nissle 1917, creating a nanocarrier with cell‐protective capabilities. Ag + and antibiotic clarithromycin (CLR) are incorporated into the nanocarrier to form CLR‐Ag + @MON@HA@OMV (CAMO), designed for the targeted treatment of gastric H. pylori infection. The HA encapsulation ensures acid‐responsive release of CLR and Ag + in the stomach, preventing premature release at non‐inflammatory sites. There is a potential for Ag⁺ in CAMO to replace Ni 2 ⁺ at the active site of urease, enhancing the bactericidal effect of CLR through urease inhibition. Furthermore, the OMV provides additional cytoprotection, mitigating cell damage and inflammation response induced by the H. pylori infection. This study introduces a safe and effective nanocarrier that eradicates H. pylori and alleviates gastric inflammation.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shanghai Municipality
  • National Key Research and Development Program of China

Zitieren

APA

Fan, H., Wong, K. I., Ma, Y., Li, M., Li, H., Wei, L., Wang, S., Yao, M., & Lu, M. (2025). Biodegradable Acid‐Responsive Nanocarrier for Enhanced Antibiotic Therapy Against Drug‐Resistant Helicobacter Pylori via Urease Inhibition. Advanced Functional Materials, 35(2). https://doi.org/10.1002/adfm.202412893

Vancouver

Fan H, Wong KI, Ma Y, Li M, Li H, Wei L, et al. Biodegradable Acid‐Responsive Nanocarrier for Enhanced Antibiotic Therapy Against Drug‐Resistant Helicobacter Pylori via Urease Inhibition. Advanced Functional Materials. 2025;35(2). doi:10.1002/adfm.202412893

BibTeX
@article{Fan2025,
  author = {Fan, Huizhen and Wong, Ka Ioi and Ma, Yingying and Li, Ming and Li, Hanqing and Wei, Li and Wang, Shen and Yao, Min and Lu, Min},
  title = {Biodegradable Acid‐Responsive Nanocarrier for Enhanced Antibiotic Therapy Against Drug‐Resistant Helicobacter Pylori via Urease Inhibition},
  journal = {Advanced Functional Materials},
  year = {2025},
  volume = {35},
  number = {2},
  doi = {10.1002/adfm.202412893}
}
Kostenlos starten →